Unlocking Gut-liver-brain Axis Communication Metabolites: Energy Metabolism, Immunity and Barriers

Overview

Journal NPJ Biofilms Microbiomes

Date 2024 Nov 25

PMID 39587086

Authors

Xiaoge Sun

Manish Shukla

Wei Wang

Shengli Li

Affiliations

Soon will be listed here.

Abstract

The interaction between the gut-microbiota-derived metabolites and brain has long been recognized in both health and disease. The liver, as the primary metabolic organ for nutrients in animals or humans, plays an indispensable role in signal transduction. Therefore, in recent years, Researcher have proposed the Gut-Liver-Brain Axis (GLBA) as a supplement to the Gut-Brain Axis. The GLBA plays a crucial role in numerous physiological and pathological mechanisms through a complex interplay of signaling pathways. However, gaps remain in our knowledge regarding the developmental and functional influences of the GLBA communication pathway. The gut microbial metabolites serve as communication agents between these three distant organs, functioning prominently within the GLBA. In this review, we provide a comprehensive overview of the current understanding of the GLBA, focusing on signaling molecules role in animal and human health and disease. In this review paper elucidate its mechanisms of communication, explore its implications for immune, and energy metabolism in animal and human, and highlight future research directions. Understanding the intricate communication pathways of the GLBA holds promise for creating innovative treatment approaches for a wide range of immune and metabolic conditions.

Citing Articles

Modulation of the Neuro-Cancer Connection by Metabolites of Gut Microbiota.

Mafe A, Busselberg D Biomolecules. 2025; 15(2).

PMID: 40001573 PMC: 11853082. DOI: 10.3390/biom15020270.

References

Mascolo N, Rajendran V, Binder H . Mechanism of short-chain fatty acid uptake by apical membrane vesicles of rat distal colon. Gastroenterology. 1991; 101(2):331-8. DOI: 10.1016/0016-5085(91)90008-9. View

Brescia P, Rescigno M . The gut vascular barrier: a new player in the gut-liver-brain axis. Trends Mol Med. 2021; 27(9):844-855. DOI: 10.1016/j.molmed.2021.06.007. View

Zheng S, Zhang H, Liu R, Huang C, Li H, Deng Z . Do short chain fatty acids and phenolic metabolites of the gut have synergistic anti-inflammatory effects? - New insights from a TNF-α-induced Caco-2 cell model. Food Res Int. 2021; 139:109833. DOI: 10.1016/j.foodres.2020.109833. View

Frampton J, Murphy K, Frost G, Chambers E . Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function. Nat Metab. 2020; 2(9):840-848. DOI: 10.1038/s42255-020-0188-7. View

Segarra M, Aburto M, Acker-Palmer A . Blood-Brain Barrier Dynamics to Maintain Brain Homeostasis. Trends Neurosci. 2021; 44(5):393-405. DOI: 10.1016/j.tins.2020.12.002. View

Layden B, Angueira A, Brodsky M, Durai V, Lowe Jr W . Short chain fatty acids and their receptors: new metabolic targets. Transl Res. 2012; 161(3):131-40. DOI: 10.1016/j.trsl.2012.10.007. View

Galea I . The blood-brain barrier in systemic infection and inflammation. Cell Mol Immunol. 2021; 18(11):2489-2501. PMC: 8481764. DOI: 10.1038/s41423-021-00757-x. View

Surana N, Kasper D . The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA. Immunol Rev. 2011; 245(1):13-26. PMC: 3243960. DOI: 10.1111/j.1600-065X.2011.01075.x. View

Xiao Y, Feng Y, Zhao J, Chen W, Lu W . Achieving healthy aging through gut microbiota-directed dietary intervention: Focusing on microbial biomarkers and host mechanisms. J Adv Res. 2024; 68:179-200. PMC: 11785574. DOI: 10.1016/j.jare.2024.03.005. View

10.

Yan H, Ajuwon K . Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway. PLoS One. 2017; 12(6):e0179586. PMC: 5487041. DOI: 10.1371/journal.pone.0179586. View

11.

Wikoff W, Anfora A, Liu J, Schultz P, Lesley S, Peters E . Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A. 2009; 106(10):3698-703. PMC: 2656143. DOI: 10.1073/pnas.0812874106. View

12.

Schonfeld P, Wojtczak L . Short- and medium-chain fatty acids in energy metabolism: the cellular perspective. J Lipid Res. 2016; 57(6):943-54. PMC: 4878196. DOI: 10.1194/jlr.R067629. View

13.

Chang P, Hao L, Offermanns S, Medzhitov R . The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2014; 111(6):2247-52. PMC: 3926023. DOI: 10.1073/pnas.1322269111. View

14.

Macpherson A, Harris N . Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004; 4(6):478-85. DOI: 10.1038/nri1373. View

15.

Liu L, Huh J, Shah K . Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS. EBioMedicine. 2022; 77:103908. PMC: 8897630. DOI: 10.1016/j.ebiom.2022.103908. View

16.

Praveenraj S, Sonali S, Anand N, Tousif H, Vichitra C, Kalyan M . The Role of a Gut Microbial-Derived Metabolite, Trimethylamine N-Oxide (TMAO), in Neurological Disorders. Mol Neurobiol. 2022; 59(11):6684-6700. DOI: 10.1007/s12035-022-02990-5. View

17.

Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M . A G protein-coupled receptor responsive to bile acids. J Biol Chem. 2003; 278(11):9435-40. DOI: 10.1074/jbc.M209706200. View

18.

Rooks M, Garrett W . Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016; 16(6):341-52. PMC: 5541232. DOI: 10.1038/nri.2016.42. View

19.

Zheng D, Liwinski T, Elinav E . Interaction between microbiota and immunity in health and disease. Cell Res. 2020; 30(6):492-506. PMC: 7264227. DOI: 10.1038/s41422-020-0332-7. View

20.

Sayin S, Wahlstrom A, Felin J, Jantti S, Marschall H, Bamberg K . Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013; 17(2):225-35. DOI: 10.1016/j.cmet.2013.01.003. View